Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2025-01-03T15:15:12.913Z Has data issue: false hasContentIssue false
  • English
  • Français

Cardiovascular Effects of Antidepressant Medications

Published online by Cambridge University Press:  06 August 2018

James P. Halper  and
J. John Mann
James P. Halper*
Affiliation:
Cornell University Medical College
J. John Mann
Affiliation:
Cornell University Medical College, New York
*
∗Correspondence: Mount Sinai Hospital and School of Medicine, New York
Get access Rights & Permissions [Opens in a new window]

Extract

Antidepressants are associated with a variety of side-effects, ranging in severity from the merely annoying to those with significant morbidity and even potential mortality. Prominent among the latter are cardiovascular effects, which have provided much of the impetus for the development of newer antidepressants such as fluoxetine. In this paper, we will review these cardiovascular effects, but as this has been previously undertaken elsewhere (e.g. Glassman & Bigger, 1981; Marshall & Forker, 1882; Glassman, 1984a), our consideration will be selective, with emphasis on methodological issues of relevance to the evaluation of new antidepressants. Since mechanisms of cardiac side-effects are best understood in relation to tricyclic antidepressants (TCAs), these will be a major focus, and will provide a background for the consideration of newer agents.

While less is known regarding the side-effects of the newer antidepressants, examination of the evolution of knowledge and opinions regarding their safety is particularly pertinent in that it illustrates the waxing and waning of enthusiasm that typically accompanies the introduction of new therapeutic agents. We review below the growing body of data regarding fluoxetine and some of the other serotonin-selective antidepressants, as well as discussing serotonergic effects on the cardiovascular system and their implications for the clinical use of these agents. Since the interactions between antidepressants and drugs used to treat cardiovascular disorders have been reviewed by Risch et al (1982) and Glassman & Salzman (1987), these will not be considered here.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 153 , Issue S3: Progress in Antidepressant Therapy , September 1988 , pp. 87 - 98
Copyright
Copyright © 1988 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aberg-Wistedt, A., Ross, S. B., Jostell, K.-G. & Sojoquist, B. (1982) A double blind study of zimeldine, a serotonin uptake inhibitor, and desipramine, a noradrenalibe uptake inhibitor, in endogenous depression. II. Biochemical findings. Acta Psychiatrica Scandinavica, 66, 66–82.Google Scholar
Alexopolous, G. S. & Shamoian, C. A. (1982) Tricyclic antidepressants and cardiac patients with pacemakers. American Journal of Psychiatry, 139, 519–520.Google Scholar
Aronson, M. D. & Hafez, H. (1986) A case of trazodone-induced ventricular tachycardia. Journal of Clinical Psychiatry, 47, 388–389.Google Scholar
Bigger, J. T. & Hoffman, B. F. (1985) Antiarrhythmic drugs. In The Pharmacologic Basis of Therapeutics (eds Gilman, A. G., Goodman, L. S., Rail, T. W. & Murad, F.). New York: MacMillan Publishing Company.Google Scholar
Boehnert, M. T. & Lovejoy, F. H. (1985) Value of the QRS duration versus the setum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. New England Journal of Medicine, 313, 474–479.CrossRefGoogle Scholar
Boston Collaborative Drug Surveillance Program (1972) Adverse reactions to tricyclic-antidepressant drugs. The Lancet, i, 529–531.Google Scholar
Brorson, L. & Wennerblom, B. (1978) Electrophysiological methods in assessing cardiac effects of the tricyclic antidepressant imipramine. Acta Medica Scandinavica, 203, 429–432.Google Scholar
Burckhardt, D., Raeder, E., Mullet, V., Imhof, P. & Neubauer, H. (1978) Cardiovascular effects of tricyclic and tetracyclic antidepressants. Journal of American Medical Association, 234, 213–216.Google Scholar
Burgess, C. D., Montgomery, S., Wadsworth, J. & Turner, P. (1979) Cardiovascular effects of amitriptyline, mianserin, zimeldine and nomifensine in depressed patients. Postgraduate Medical Journal, 55, 704–708.CrossRefGoogle ScholarPubMed
Burgess, C. D., Hames, T. K. & George, C. F. (1982) The electrocardiographic and anticholinergic effects of trazodone and imipramine in man. European Journal of Clinical Pharmacology, 23, 417–421.Google Scholar
Burrows, G. D., Davies, B., Hamer, A. & Vohra, J. (1979) Effect of mianserin on cardiac conduction. Medical Journal of Australia, 2, 97–98.Google Scholar
Callaham, M. & Kassel, D. (1985) Epidemiology of fatal tricyclic antidepressant ingestion: implications for management. Annals of Emergency Medicine, 14, 1–9.Google Scholar
Chouinard, G. (1985) A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of out-patients with major depressive disorders. Journal of Clinical Psychiatry, 46, 32–37.Google Scholar
Claghorn, J., Gershon, S. & Goldstein, B. J. (1983) Zimeldine tolerability in comparison to amitriptyline and placebo: findings from a multicentre trial. Acta Psychiatrica Scandinavica, 68 (Suppl. 308), 104–114.Google Scholar
Connolly, S. J., Mitchell, B., Swerdlow, C. D., Mason, J. W. & Winkle, R. A. (1984) Clinical efficacy and electrophysiology of imipramine for ventricular tachycardia. American Journal of Cardiology, 53, 516–521.Google Scholar
Coull, D. C., Dingwall-Fordyce, I., Crooks, J., Scott, A. M. & Weir, D. R. (1970) Amitriptyline and cardiac disease. The Lancet, ii, 590–591.Google Scholar
Crome, P. (1982) Antidepressant overdosage. Drugs, 23, 431–461.Google Scholar
Coppen, A. & Kopera, H. (1978) Workshop on the clinical pharmacology and efficacy of mianserin. British Journal of Clinical Pharmacology, 5 (Suppl.), 91S–99S.Google Scholar
Curtis, R. A., Giacona, N., Burrows, D., Baumen, J. L. & Schaeffer, M. (1984) Fatal maprotoline intoxication. Drug Intelligence and Clinical Pharmacy, 18, 716–720.Google Scholar
Davidson, J. & Turnbull, C. D. (1986) The effects of iso-carboxazid on blood pressure and pulse. Journal of Clinical Psychopharmacology, 6, 139–143.Google Scholar
Dessain, E. C., Schatzberg, A. F., Wood, B. T. & Cole, J. O. (1986) Maprotoline treatment in depression. Archives of General Psychiatry, 43, 86–90.Google Scholar
Dugas, J. E. & Weber, S. S. (1982) Amoxapine. Drug Intelligence and Clinical Pharmacy, 16, 199–204.CrossRefGoogle ScholarPubMed
Edwards, J. G. & Goldie, A. (1983) Mianserin, maprotoline and intracardiac conduction. British Journal of Clinical Pharmacology, 15, 2495–2545.Google Scholar
Eklund, K., Dunbar, G. C., Pinder, R. M. & Steffensen, K. (1985) Mianserin and imipramine in the treatment of elderly depressed patients. Acta Psychiatrica Scandinavica, 72 (Suppl. 320), 54–59.CrossRefGoogle Scholar
Feighner, J. P. & Cohn, J. (1985) Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. Journal of Clinical Psychiatry, 46, 20–25.Google Scholar
Fisch, C. (1985) Effect of fluoxetine on the electrocardiogram. Journal of Clinical Psychiatry, 46, 42–44.Google Scholar
Freyschuss, V., Sjoquist, F., Tuck, D. & Asberg, M. (1970) Circulatory effects in man of nortriptyline, a tricyclic antidepressant drug. Pharmacologia Clinica, 2, 68–71.Google Scholar
Frommer, D. A., Kulig, K. W., Marx, J. A. & Rumack, B. (1987) Tricyclic antidepressant overdose. Journal of the American Medical Association, 257, 521–526.Google Scholar
Fuller, R. W., Holland, D. R., Yen, T. T., Bemis, K. G. & Stumm, N. B. (1979) Antihypertensive effects of fluoxetine and L-5-hydroxytryptophan in rats. Life Sciences, 25, 1237–1242.CrossRefGoogle ScholarPubMed
Gamble, D. I. & Peterson, L. G. (1986) Trazodone overdose: four years of experience from voluntary reports. Journal of Clinical Psychiatry, 47, 544–546.Google Scholar
Ghose, K., Coppen, A. & Turner, P. (1976) Autonomic actions and interactions of mianserin hydrochloride in patients with depressive illness. Psychopharmacology, 49, 201–204.Google Scholar
Giardina, E.-G. V., Bigger, J. T., Glassman, A. H., Perel, J. M. & Kantor, S. J. (1979) The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations. Circulation, 60, 1045–1052.Google Scholar
Giardina, E.-G. V., Bigger, J. T., Glassman, A. H., Perel, J. M., Saroff, A. L., Roose, S. P., Siris, S. C. & Davis, J. C. (1983) Effects of desmethylimipramine and imipramine on left ventricular function and the ECG: a randomised crossover design. International Journal of Cardiology, 2, 375–385.Google Scholar
Giardina, E.-G. V., Johnson, L. L., Vita, J., Bigger, J. T. & Brem, R. F. (1985) Effect of imipramine and nortriptyline on left ventricular function and blood pressure in patients treated for arrhythmias. American Heart Journal, 109, 992–998.CrossRefGoogle ScholarPubMed
Glassman, A. H. (1984a) Cardiovascular effects of tricyclic antidepressants. Annual Review of Medicine, 35, 503–511.CrossRefGoogle ScholarPubMed
Glassman, A. H. (1984b) The newer antidepressant drugs and their cardiovascular effects. Psychopharmacology Bulletin, 20, 272–279.Google Scholar
Glassman, A. H. & Bigger, J. T. (1981) Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review. Archives of General Psychiatry, 38, 815–820.Google Scholar
Glassman, A. H., Giardina, E. V., Perel, J. M., Bigger, J. T., Kantor, S. J. & Davies, M. (1979) Clinical characteristics of imipramine induced orthostatic hypotension. The Lancet, i. 468–472.Google Scholar
Glassman, A. H., Johnson, L. L., Giardina, E-C. V., Walsh, B. T., Roose, S. P., Cooper, T. B. & Bigger, J. T. (1983) The use of imipramine in depressed patients with congestive heart failure. Journal of the American Medical Association, 250, 1997–2001.Google Scholar
Glassman, R. & Saltzman, C. (1987) Psychopharmacology: interactions between psychotropic and other drugs: an update. Hospital and General Psychiatry, 38, 236–242.Google Scholar
Goldman, L. S., Alexander, R. L. & Luchins, D. J. (1986) Monoamine oxidase inhibitors and tricyclic antidepressants: Comparison of their cardiovascular effects. Journal of Clinical Psychiatry, 47, 225–229.Google Scholar
Gommoll, A. W. & Byrne, J. E. (1981) Cardiovascular effects of trazodone in animals. Journal of Clinical Psychopharmacology, 1 (Suppl.), 70–75.CrossRefGoogle Scholar
Guzzardi, L. (1983) Monamine oxidase inhibitors. In Clinical Management of Poisoning and Drug Overdose (eds Haddad, L. M. & Winchester, J. F.). Philadelphia: W. B. Saunders Company.Google Scholar
Hagerman, G. A. & Hanashiro, P. K. (1981) Reversal of tricyclic-antidepressant-induced cardiac conduction abnormalities by phenytoin. Annals of Emergency Medicine, 10, 82–86.Google Scholar
Herrmann, H. E., Kaplan, L. M. & Bieres, B. E. (1983) Q-T prolongation and torsade de pointes ventricular tachycardia produced by the tetracyclic antidepressant maprotoline. American Journal of Cardiology, 51, 904–906.Google Scholar
Himmelhoch, J. M. (1981) Cardiovascular effects of trazodone in humans. Journal of Clinical Psychopharmacology, 1 (Suppl.), 765–815.Google Scholar
Himmelhoch, J. M., Schechtman, K. & Auchenbach, R. (1984) The role of trazodone in the treatment of depressed cardiac patients. Psychopathology, 17 (Suppl. 2), 51–63.Google Scholar
Hyatt, M. & Messer, M. (1986) Yohimbine and imipramine-induced orthostasia. American Journal of Psychiatry, 143, 389–390.Google Scholar
Irwin, M. & Spar, J. E. (1983) Reversible cardiac conduction abnormality associated with trazodone administration. American Journal of Psychiatry, 140, 945–946.Google Scholar
Janowsky, D., Curtis, G., Zisook, S., Kuhn, K., Resovsky, K. & Le Winter, M. (1983) Ventricular arrhythmias possibly aggravated by trazodone. American Journal of Psychiatry, 140, 796–797.Google Scholar
Jarvick, L. F., Read, S. L., Muntz, J. & Neshkej, R. E. (1983) Pretreatment orthostatic hypotension in geriatric depression: prediction of response to imipramine and doxepin. Journal of Clinical Psychopharmacology, 3, 368–371.Google Scholar
Jue, S. G., Dawson, G. W. & Brogden, R. N. (1982) Amoxapine. A review of its pharmacology and efficacy in depressed states. Drugs, 24, 1–23.Google Scholar
Kantor, S. J., Bigger, J. T., Glassman, A. M., Macken, D. L. & Perel, J. M. (1975) Imipramine-induced heart block. A longitudinal case study. Journal of the American Medical Association, 231, 1364–1366.Google Scholar
Kopera, H. (1983) Lack of anticholinergic and cardiovascular effects of mianserin, studies in healthy subjects and heart patients. Acta Psychiatrica Scandinavica Suppl. 302, 81-89.Google Scholar
Kopera, H. & Schenck, (1977) Poisoning with antidepressants. British Medical Journal, ii, 773.Google Scholar
Kronig, M. H., Roose, S. P., Walsh, B. T., Woodring, S. & Glassman, A. H. (1983) Blood pressure effects of phenelzine. Journal of Clinical Psychopharmacology, 3, 307–310.CrossRefGoogle ScholarPubMed
Kuhn, D. M., Wolf, W. A. & Lovenberg, W. (1980) Review of the role of the central serotonergic neuronal system in blood pressure regulation. Hypertension, 2, 243–255.Google Scholar
Kulig, K. (1986) Management of poisoning associated with “newer” antidepressant agents. Annals of Emergency Medicine, 15, 1039–1045.Google Scholar
Lapierre, Y., Browne, M., Horn, E., Oyewumi, L. K., Sanantidis, D., Roberts, N., Badoe, K. & Tessier, P. (1987) Treatment of major affective disorder with fluvoxamine, 48, 65–68.Google ScholarPubMed
Lecrubier, Y., Puech, A. J. & des Lauriers, A. (1981) Favorable effects of yohimbine on clomipramine-induced orthostatic hypotension: a double-blind study. British Journal of Pharmacology, 12, 90–93.Google Scholar
Lemberger, L., Bergstrom, R., Wolen, R. L., Farid, N., Enas, G. G. & Aronofe, C. R. (1985) Fluoxetine: clinical pharmacology and physiologic disposition. Journal of Clinical Psychiatry, 46, 14–19.Google Scholar
Lippman, S., Bradford, P., Manshadi, M. & Mather, S. (1983) Trazodone toxicity. American Journal of Psychiatry, 140, 1383.Google Scholar
Lippman, S., Manshadi, M. S. & Gultchin, A. (1985) Monoamine oxidase inhibitors for depressed cardiac patients. Journal of Clinical Psychiatry, 46, 545–546.Google Scholar
Lown, B. & Lampert, S. (1985) Sudden cardiac death. In Coronary Heart Disease (eds Connor, W. E. & Bristow, J. D.). Philadelphia: J. B. Lippincott.Google Scholar
Luchins, D. J. (1983) Review of clinical and animal studies comparing the cardiovascular effects of doxepin and other tricyclic antidepressants. American Journal of Psychiatry, 140, 1006–1009.Google Scholar
Macquire, K. P., Norman, T. R., Burrows, G. D. & Scoggins, (1982) A pharmacokinetic study of mianserin. European Journal of Clinical Pharmacology, 21, 517–522.Google Scholar
Magni, G. (1987) Mianserin in the treatment of elderly depressives. Journal of the American Geriatric Society, 35, 707–708.Google Scholar
Marshall, J. B. & Forker, A. D. (1982) Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose and management of complications. American Heart Journal, 103, 401–414.Google Scholar
McGrath, P. J., Blood, D. K., Stewart, J. W., Harrison, W. et al (1987) A comparative study of the electrocardiographic effects of phenelzine, tricyclic antidepressants, mianserin and placebo. Journal of Clinical Psychopharmacology, 7, 335–339.CrossRefGoogle ScholarPubMed
Moir, O. C., Cornwell, W. B., Dingwall-Fordyce, I., Crooks, J., O'Malley, K. & Turnbull, M. J. (1972) Cardiotoxicity of amitriptyline. The Lancet, ii, 561–564.Google Scholar
Montgomery, S. (1983) Advances with antidepressants: clinical experiences with mianserin. Acta Psychiatrica Scandinavica, 67 (Suppl. 305), 90–94.Google Scholar
Muller, O. F., Goodman, N. & Bellet, S. (1961) The hypotensive effect of imipramine hydrochloride inpatients with cardiovascular disease. Clinical Pharmacology and Therapeutics, 2, 300–307.Google Scholar
Nelson, J. C., Jatlow, P. I., Bock, J., Quinlan, D. M. & Bowers, M. B. (1982) Major adverse reactions during desipramine treatment. Archives of General Psychiatry, 39, 1055–1061.Google Scholar
Pichot, P., Dreyfus, J. F. & Pull, C. (1978) A double-blind multicentre trial comparing mianserin with imipramine. British Journal of Clinical Pharmacology, 5 (Suppl.), 87S–90S.Google Scholar
Pohl, R., Bridges, M., Rainey, J. M., Boudulas, H. & Teragani, V. K. (1986) Effects of trazodone and desipramine on cardiac rate and rhythm in a patient with preexisting cardiovascular disease. Journal of Clinical Psychopharmacology, 6, 380–381.Google Scholar
Pollack, M. H. & Rosenbaum, J. F. (1987) Management of antidepressant-induced side effects: a practical guide for the clinician. Journal of Clinical Psychiatry, 48, 3–8.Google Scholar
Pottage, A. & Groschinsky-Grind, M. (1983) Cardiovascular effects of zimeldine. Acta Psychiatrica Scandinavica, 68 (Suppl. 308), 125–130.Google Scholar
Prange, A. J., McCurdy, R. C., Cochrane, C. M. (1967) The systolic blood pressure response of depressed patients to infused norepinephrine. Journal of Psychiatric Research, 5, 1–13.CrossRefGoogle ScholarPubMed
Preskorn, S. H. & Irwin, H. A. (1982) Toxicity of tricyclic antidepressants - kinetics, mechanism, intervention: a review. Journal of Clinical Psychiatry, 43, 151–156.Google Scholar
Rabkin, J. G., Quitkin, F. M., McGrath, P., Harrison, W. & Tricamo, E. (1985) Adverse reactions to monoamine oxidase inhibitors. Part II. Journal of Clinical Psychopharmacology, 5, 2–9.Google Scholar
Raeder, E. A., Zinsli, M. & Burckhardt, D. (1979) Effect of maprotoline on cardiac arrhythmias. British Medical Journal, 2, 102–103.Google Scholar
Rausch, J. L., Pauline, D. M. & Newman, P. E. (1984) Complete heart block following a single dose of trazodone. American Journal of Psychiatry, 141, 1472–1473.Google Scholar
Rawling, D. A. & Fozzard, H. A. (1979) Effects of imipramine on cellular electrophysiological properties of cardiac purkinje fibers. Journal of Pharmacology and Experimental Therapeutics, 209, 371–375.Google Scholar
Ray, W. A., Griffin, M. R., Schaffner, W., Baugh, D. K. & Melton, L. J. (1987) Psychotropic drug use and the risk of hip fracture. New England Journal of Medicine, 316, 363–369.Google Scholar
Risch, S. C., Groom, G. P. & Janowsky, D. S. (1982) The effects of psychotropic drugs on the cardiovascular system. Journal of Clinical Psychiatry, 43, 16–31.Google Scholar
Robinson, D. S. (1984) Adverse reactions, toxicities and drug interactions of newer antidepressants: Anticholinergic, sedative and other side effects. Psychopharmacology Bulletin, 20, 280–290.Google Scholar
Robinson, D. S., Nies, A., Corcella, J., Cooper, T. B., Spencer, C. & Keefover, R. (1982) Cardiovascular effects of phenelzine and amitriptyline in depressed outpatients. Journal of Clinical Psychiatry, 43, 8–15.Google Scholar
Roos, J. C. (1983) Cardiac effects of antidepressant drugs. A comparison of the tricyclic antidepressants and fluvoxamine. British Journal of Clinical Pharmacology, 15, 439S–445S.Google Scholar
Roose, S. P., Glassman, A. H., Siris, S., Walsh, B. T., Bruno, R. L. & Wright, L. B. (1981) Comparison of imipramine and nortriptyline-induced orthostatic hypotension: A meaningful difference. Journal of Clinical Psychopharmacology, 1, 316–319.Google Scholar
Roose, S. P., Giardina, E. G. V., Johnson, L. L., Walsh, B. T., Woodring, S. & Bigger, J. T. (1986) Nortriptyline in depressed patients with left ventricular impairment. Journal of the American Medical Association, 256, 3253–3257.Google Scholar
Roose, S. P., Giardina, E. G. V., Johnson, L. L., Walsh, B. T., Woodring, S. & Bigger, J. T. (1987a) Cardiovascular effects of imipramine and buproprion in depressed patients with congestive heart failure. Journal of Clinical Psychopharmacology, 7, 274–251.Google Scholar
Roose, S. P., Giardina, E. G. V., Johnson, L. L., Walsh, B. T., Woodring, S. & Bigger, J. T. (1987b) Tricyclic antidepressants in depressed patients with cardiac conduction disease. Archives of General Psychiatry, 44, 273–275.Google Scholar
Ruskin, J. N., McGovern, G., Garan, H., DiMario, J. P. & Kelley, E. (1983) Antiarrhythmic drugs: A possible cause of out-of-hospital cardiac arrest. New England Journal of Medicine, 309, 1302–1306.Google Scholar
Schneider, L. S., Sloane, R. B., Staples, F. R. & Bender, M. (1986) Pretreatment orthostatic hypotension as a predictor of response to nortriptyline in geriatric depression. Journal of Clinical Psychopharmacology, 6, 172–176.CrossRefGoogle ScholarPubMed
Stark, P. & Hardison, C. D. (1985) A review of multicentre controlled studies of fluoxetine vs imipramine and placebo in outpatients with major depressive disorder. Journal of Clinical Psychiatry, 48, 53–58.Google Scholar
Steinberg, M. I., Smallwood, J. K., Holland, D. R., Bymaster, F. P. & Bemis, K. G. (1986) Hemodynamic and electrocardiographic effects of fluoxetine and its major metabolite, norfluoxetine, in anesthetised dogs. Toxicology and Applied Pharmacology, 82, 70–79.Google Scholar
Thayssen, P., Bjerre, M., Kragh-Sprensen, P., Miller, M. J., Petersen, D. L., Kristensen, C. B. & Gram, L. F. (1981) Cardiovascular effects of imipramine and nortriptyline in elderly patients. Psychopharmacology, 74, 360–364.Google Scholar
U-Prichard, D. C., Greenberg, D. A., Sheehan, P. P. & Snyder, S. (1978) Tricyclic depressants: therapeutic properties and affinity for alpha adrenergic binding sites in the brain. Science, 199, 197–198.Google Scholar
Veith, R. C., Raskins, M. A., Caldwell, J. H., Barnes, R. F., Gumbrecht, G. & Ritchie, J. L. (1982) Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. New England Journal of Medicine, 306, 954–959.Google Scholar
Vohra, J. & Burrows, G. D. (1974) Cardiovascular complications of tricyclic antidepressant overdose. Drugs, 8, 432–437.Google Scholar
Vohra, J. & Burrows, G. D., Hunt, D. & Sloman, G. (1975) The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction. European Journal of Cardiology, 3, 219–227.Google Scholar
Wedin, G. P., Oderda, G. M., Klein-Schwartz, W. & Gorman, R. L. (1986) Relative toxicity of cyclic antidepressants. Annals of Emergency Medicine, 15, 797–804.Google Scholar
Weld, F. M. & Bigger, J. T. (1980) Electrophysiological effects of imipramine on ovine cardiac purkinje and ventricular muscle fibers. Circulation Research, 46, 167–175.Google Scholar
Wernicke, J. F. (1985) The side effect profile and safety of fluoxetine. Journal of Clinical Psychiatry, 46, 59–67.Google Scholar
Wilner, P. J., Brown, R. P., Sweeney, J. A., Halper, J. P., Tierney, H. & Mann, J. J. (1987) Blunted orthostatic response in major depressives. American Psychiatric Association 140th Annual Meeting New Research Abstracts NR 33.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.